Quick answer: the most common Mounjaro side effects
Most people who experience side effects notice them around dose starts or increases. The most reported reactions are:
- Nausea, vomiting or burping
- Diarrhoea or constipation
- Stomach discomfort, bloating or indigestion (dyspepsia)
- Decreased appetite and early fullness
- Fatigue, headache or dizziness (especially with poor intake)
- Injection‑site reactions (mild redness, itch, small lump)
These are usually mild to moderate and tend to improve over 2–8 weeks as your dose stabilises and your body adapts.
Why Mounjaro side effects happen
Tirzepatide activates GIP and GLP‑1 receptors. This slows stomach emptying, reduces appetite, and improves insulin signalling. The same mechanisms that help glucose control and weight can trigger gastrointestinal symptoms—particularly if food portions stay the same or the dose is increased too quickly.
Side effects are most likely:
- In the first 1–3 injections
- For 3–7 days after each dose increase
- When dehydrated, after large/high‑fat meals, or with alcohol
Common and mild side effects (what’s typical)
Frequency varies by dose and individual response. In clinical studies, the following were commonly reported:
- Gastrointestinal: nausea, vomiting, diarrhoea, constipation, abdominal pain, dyspepsia, reflux/heartburn, bloating, gas, belching
- Appetite and taste: reduced appetite, altered taste, early satiety
- General: fatigue, headache, dizziness (can reflect low intake or dehydration)
- Local: mild injection‑site redness, tenderness, itching or small nodules
Contact your prescriber if common symptoms persist beyond 6–8 weeks, significantly impact eating/drinking, or worsen after you have already stabilised on a dose.
Serious risks and red‑flag symptoms
Seek urgent medical care if you develop any of the following:
- Severe, persistent abdominal pain (may radiate to the back), fever, or repeated vomiting—possible pancreatitis
- Right‑upper abdominal pain with fever, jaundice, pale stools or dark urine—possible gallbladder problems
- Signs of dehydration or kidney problems: minimal urine, confusion, persistent dizziness, very dry mouth, fast heartbeat
- Severe constipation, abdominal swelling, or inability to pass gas—possible bowel obstruction/ileus
- Allergic reaction: rash, swelling of face/lips/tongue, difficulty breathing
- Low blood sugar if used with insulin or sulfonylureas: shakiness, sweating, confusion, fast heartbeat
- Sudden vision changes—especially with rapid glucose improvements
In an emergency in Australia, call 000.
When to contact your doctor vs go to hospital
- Contact your prescriber within 24–48 hours for moderate vomiting/diarrhoea, worsening reflux, signs of dehydration, or if you cannot keep fluids down.
- Go to urgent care or call 000 for the red‑flag symptoms listed above, or if you feel acutely unwell.
Do not increase your dose while symptoms are active. Dose adjustments should be clinician‑guided.
Side‑effect timeline: when they start and how long they last
- Start of therapy (2.5 mg for 4 weeks): most symptoms appear in the first 1–3 doses and often improve as your body adapts.
- After each titration (to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, 15 mg): a short flare of GI symptoms is common for 3–7 days.
- Stabilisation: many people report settling within 2–8 weeks at a steady dose.
Practical ways to reduce side effects
- Hydration first: aim for regular fluids; consider oral rehydration if vomiting/diarrhoea occurs.
- Small, slow, simple: smaller portions, eat slowly, pause when full.
- Lower fat and spice at first: high‑fat meals tend to worsen nausea/reflux.
- Protein forward: prioritise protein to protect lean mass; choose gentle sources (eggs, yoghurt, fish, tofu).
- Manage constipation: fibre‑rich foods, gentle movement, adequate fluids; discuss stool softeners if needed.
- Time your dose: many prefer evening doses; avoid dose day large meals or alcohol.
- Do not rush increases: allow at least 4 weeks between steps and only if well‑tolerated.
- Check other medicines: some can worsen reflux/constipation—review with your GP or pharmacist.
Who should avoid or use Mounjaro with caution
- Personal or family history of medullary thyroid carcinoma (MTC) or MEN2—contraindicated
- History of pancreatitis—use caution; discuss risks
- Severe gastrointestinal disease (e.g., gastroparesis)—often not suitable
- Gallbladder disease—monitor for symptoms
- Significant renal impairment—risk increases with dehydration
- Pregnancy or breastfeeding—not recommended; discuss contraception and washout before trying to conceive
- Under 18 years—safety and efficacy not established
- Fasting procedures or recent anaesthesia—tell your anaesthetist; guidance on holding GLP‑1/GIP agents varies
Interactions and special notes for Australia
- Diabetes medicines: risk of hypoglycaemia when combined with insulin or sulfonylureas—your doctor may reduce those doses.
- Oral medicines: delayed gastric emptying can affect absorption; time‑critical drugs may need review.
- Alcohol: may worsen nausea or hypoglycaemia risk—limit especially during titration.
- Australian guidance: review the TGA Consumer Medicine Information (CMI) and Product Information (PI) for tirzepatide; follow prescriber advice.
Frequently asked questions
How long do Mounjaro side effects last?
Most settle within 2–8 weeks, particularly after you hold a steady dose. Flare‑ups are common for several days after each dose increase.
Can I take anti‑nausea medication with Mounjaro?
Often yes, under medical guidance. Your prescriber may suggest options if lifestyle measures are not enough. Avoid self‑medicating without advice.
Does Mounjaro cause hair loss?
Tirzepatide is not known to directly cause hair loss. Rapid weight loss, low protein intake or stress may contribute—focus on adequate nutrition and speak to your doctor if you notice shedding.
Will side effects mean the medicine isn’t working?
No. Side effects reflect how the drug works for appetite and gastric emptying. However, severe or persistent symptoms need medical review and may require dose changes.
Is Mounjaro approved for weight loss in Australia?
Mounjaro (tirzepatide) is approved for type 2 diabetes in Australia. A tirzepatide brand for weight management has been approved, but availability and eligibility vary—discuss current options with your doctor.
Should I stop Mounjaro before surgery?
Tell your surgeon and anaesthetist you use tirzepatide. Guidance varies by procedure and risk; your team will advise if and when to pause.
What if I can’t tolerate the next dose up?
Hold at your current dose longer, or step back down under clinician guidance. There’s no benefit to pushing a dose that keeps you unwell.
Can Mounjaro worsen reflux?
Yes—slower stomach emptying and meal size can increase reflux. Smaller portions, lower‑fat meals and timing adjustments often help. Seek review if persistent.
Where can I report a suspected side effect?
Speak with your prescriber and pharmacist. You can also report adverse events to the TGA. If you’re unsure what to do next, use the form below to request guidance.
Side‑effect support and questions
If you’re experiencing symptoms or want help planning dose steps, use this form. A clinician‑aligned team member will reply with guidance, next steps, or a referral pathway.
If your symptoms are severe or you think you are having an emergency, call 000 immediately.
Final takeaway
Most Mounjaro side effects are gastrointestinal, appear during dose starts or increases, and tend to improve with time and simple adjustments. Know the red flags, stay hydrated, increase doses slowly, and ask for help early if symptoms persist or worry you.